Tauopathies and synucleinopathies: Do cerebrospinal fluid β-amyloid peptides reflect disease-specific pathogenesis?

By Mollenhauer B.   Bibl M.   Esselmann H.   Steinacker P.   Trenkwalder C.   Wiltfang J.   Otto M.  

Journal of Neural Transmission, Vol. 114, Iss. 7, 2007-07 ,pp. : 919-927

Springer Publishing Company

Access to resources Recommend Favorite

Pathological properties of the Parkinson’s disease-associated protein DJ-1 in α-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick’s disease

By Neumann Manuela   Müller Veronika   Görner Karin   Kretzschmar Hans   Haass Christian   Kahle Philipp  

Acta Neuropathologica, Vol. 107, Iss. 6, 2004-06 ,pp. : 489-496

Springer Publishing Company

Access to resources Recommend Favorite

THE DEMENTIAS.

By Wilcock G. K.  

Brain, Vol. 122, Iss. 6, 1999-06 ,pp. : 1202-1204

Oxford University Press

Access to resources Recommend Favorite

Prospect of therapeutic approaches to tauopathies

By Roder Hanno  

Journal of Molecular Neuroscience, Vol. 20, Iss. 2, 2003-04 ,pp. : 197-201

Humana Press, Inc

Access to resources Recommend Favorite

Targeting Heat Shock Proteins in Tauopathies

By  

Current Alzheimer Research, Vol. 7, Iss. 8, 2010-12 ,pp. : 677-684

Bentham Science Publishers

Access to resources Recommend Favorite